1 Antivirals in the Draft CDC Pandemic Plan David K. Shay Influenza Branch National Center for Infectious Diseases Centers for Disease Control and Prevention.

Slides:



Advertisements
Similar presentations
Hospital Pandemic Influenza Planning by Ed Lydon, CVPH.
Advertisements

San Francisco Bay Area Advanced Practice Center. Who are we? San Francisco Bay Area Advanced Practice Center San Francisco Department of Public Health.
Who Holds the Key? Developing Antiviral Treatment Strategies for Healthcare Workers During an Influenza Pandemic Sallie Shipman, BSN, RN Alabama Department.
Vaccines & Antivirals: Provincial Stockpile & Distribution Plans Pandemic Planning Education Day for Community Laboratories Joanne Rey, Vaccine and Antiviral.
Pandemic Influenza Planning Medical Surge - Hospitals Barbara Pletz EMS Administrator San Mateo County.
For Official Use Only. Public Health and EMS How Long Do You Have to Live? For Official Use Only.
Maryland 2008 Statewide Pandemic Influenza Exercise and CRA Albert Romanosky MD, PhD Office of Preparedness and Response Maryland Department of Health.
Christa-Marie Singleton, MD, MPH Associate Director for Science
Strategic National Stockpile Pandemic Influenza Countermeasures
U.S. Pandemic Influenza Preparedness and Response: Planning and Activities “The pandemic influenza clock is ticking. We just don’t know what time it is.”
Capability Cliff Notes Series PHEP Capability 8—Medical Dispensing and Countermeasures What Is It And How Will We Measure It?
Capability Cliff Notes Series PHEP Capability 8—Medical Dispensing and Countermeasures What Is It And How Will We Measure It?
Pandemic Influenza: Role and Responsibility of Local Public Health Richard M. Tooker, MD Chief Medical Officer Kalamazoo County Health and Community Services.
Pandemic Influenza Catherine Donovan, MD. MHSc. CIPHI, Newfoundland and Labrador, Oct 25, 2005 Eastern Region
Miriam Nuño Harvard School of Public Health, USA Gerardo Chowell Los Alamos National Laboratory, USA Abba Gumel University of Manitoba, Canada AIMS/DIMACS/SACEMA.
1. 2 The Public Health Agency of Canada Pandemic Influenza Preparedness: An Overview Dr. Paul Gully Deputy Chief Public Health Officer Ottawa, 19 January.
RADM Ali S. Khan, MD, MPH Director, Office of Public Health Preparedness and Response Bridging the Gaps: Public Health and Radiation Emergency Preparedness.
Pandemic Influenza Planning Seattle & King County, Washington, USA Jeffrey S. Duchin, M.D. Chief, Communicable Disease Control, Epidemiology & Immunization.
Hepatitis and Liver Cancer A National Strategy for Prevention and Control of Hepatitis B and C.
Health System Response to Pandemic Influenza: A Clinician's Perspective Mary M. Klote, MD Walter Reed Army Medical Center.
Preparing for the next flu pandemic MINISTRY OF HEALTH SINGAPORE 20 Jan 2006.
Introduction to Developing a Vaccination Strategy for Smallpox Preparedness Department of Health and Human Services Centers for Disease Control and Prevention.
Melissa House, Ph.D.: Public Health Walden University PUBH Instructor: Dr. Robert Marino Spring Qtr, 2011 D ISASTER P REPAREDNESS P ANDEMIC I NFLUENZA.
Pandemic Influenza Preparedness Kentucky Department for Public Health Department for Public Health.
Pandemic Influenza Response Planning on College Campuses Felix Sarubbi, MD Division of Infectious Diseases James H. Quillen College of Medicine.
HealthSanté CanadaCanada Influenza Prevention and Control in Canada Arlene King, MD, MHSc, FRCPC Director, Immunization and Respiratory Infections Division,
Departmental Perspectives on Viral Hepatitis
Pandemic Preparedness: It’s not if…. but when An educational session prepared by the Pandemic Preparedness Response Team of the Kidney Community Emergency.
Pan American Health Organization.. Protecting the Health of Health Care Workers: Experience from the Americas Marie-Claude Lavoie Decision Making for Using.
ATP NVAC PIWG Report Pandemic Influenza Antiviral Strategies and Priority Groups Andrew T. Pavia M.D. University of Utah.
Raymond A. Strikas, MD Associate Director for Adult Immunization Immunization Services Division National Immunization Program Coordinating Center for Infectious.
Pandemic Influenza. Guidance for Pandemic Influenza: Infection Control in Hospitals and Primary Care Settings UK Pandemic Influenza Contingency Plan Operational.
New Jersey Preparedness Training Consortium Continuing Education for health care professionals “moduleNewJerseyv1” NJ Statewide Response to Health Threats.
Stanislaus County It’s Not Flu as Usual It’s Not Flu as Usual Pandemic Influenza Preparedness Renee Cartier Emergency Preparedness Manager Health Services.
Local Emergency Response to Biohazardous Incidents Dr. Elizabeth Whalen, MD Medical Director Albany County Health Department April 8, 2005 Northeast Biological.
Antiviral Stockpiling for Novel Strains of Influenza.
National Public Health Performance Standards Program Overview Presentation.
1 PREPARATION AND RESPONSE OF THE HEALTH SERVICES TO AN INFLUENZA PANDEMIC.
Planning for Resiliency. Primary Reference Emergency Management Principles and Practices for Healthcare Systems, The Institute for Crisis, Disaster and.
THE NATIONAL INFLUENZA VACCINE SUMMIT: UPDATE Raymond A. Strikas, M.D. Immunization Services Division National Immunization Program Coordinating Center.
HHS Pandemic Influenza Preparedness Planning Julie Louise Gerberding, MD, MPH.
Access to antiviral stockpiles for pandemic use – an industry perspective Dr. David Reddy, Pandemic Influenza Taskforce Leader, F.Hoffmann-La Roche Ltd,
BIOTERRORISM: SOUTH CAROLINA RESPONDS. OBJECTIVES l To understand the response to a bioterrorist act through use of the unified incident command system.
Guidance on Antiviral Drug Use and Stockpiling of Antiviral Drugs and Respirators and Facemasks National antiviral drug use guidance Ben Schwartz, HHS.
EPIDEMIOLOGY DENGUE, MALARIA Priority Areas for Planning Dengue Emergency Response 1. Establish a multisectoral dengue action committee.
Office of Public Health Preparedness and Response Division of Strategic National Stockpile Ben Erickson Public Health Analyst Inventory Management Tracking,
Food and Drug Administration
Antiviral Use and Masks Lynn Sosa, MD Deputy State Epidemiologist August 24, 2009.
CONNECTICUT PANDEMIC PLANNING Meg Hooper, MPA Connecticut Department of Public Health 9 Oct 2008.
Public Health Issues Associated with Biological and Chemical Terrorism Scott Lillibridge, MD Director Bioterrorism Preparedness and Response Activity National.
U.S. Pandemic Influenza Preparedness and Response: Update & Progress Report “The pandemic influenza clock is ticking. We just don’t know what time it is.”
Governor’s Taskforce for Pandemic Influenza Preparedness Issue Paper Credible and Effective Decision-making Workgroup Members Robert Rolfs, State Epidemiologist,
PHEP Capabilities John Erickson, Special Assistant Washington State Department of Health
The Vermont Department of Health Overview of Pandemic Influenza Regional Pandemic Planning Summits 2006 Guidance Support Prevention Protection.
Training structure Safety and good quality work Module 1: Knowledge about Ebola Virus Disease Support from the community Support from the hospital.
CIFOR Council to Improve Foodborne Outbreak Response CIFOR Guidelines and CIFOR Toolkit Donald J. Sharp, MD, DTM&H Food Safety Office National Center for.
Conclusions 3 rd Meeting of National Influenza Centres in the Western Pacific and South East Asia Regions 18 – 20 August 2009 Beijing, China.
Bioterrorism and Emergency Preparedness November 16, 2005 Jon Huss Director, Community Preparedness Section.
An Overview of Pandemic Influenza Planning in the United States NAPHSIS Annual Meeting June 7, 2006 David K. Shay Influenza.
Office of Public Health Preparedness and Response Division of Emergency Operations Centers for Disease Control and Prevention.
Pandemic Influenza: Planning and Preparedness Ben Schwartz, M.D. National Vaccine Program Office, U.S. Department of Health and Human Services NVAC Meeting,
Adult Immunization: Goals, Challenges, and a role for the National Vaccine Advisory Committee October 22, 2007 Raymond A. Strikas, MD National Vaccine.
Current Pandemic H1N1 Updates in the Philippines Department of Health, Philippines Juan M. Lopez, MD, PGradDipPH, MPH Aldrin Q. Reyes, RN.
WASHTENAW COUNTY HEALTH DEPARTMENT 555 TOWNER ST. YPSILANTI, MI Strategic National Stockpile Overview: Volunteer Training.
PANDEMIC H1N1 IN HANOI-VIETNAM: OVERVIEW AND RESPONSE.
Outline of Current Situation Survey on HIV/AIDS (Proposal) Ms. Keiko Dozono Director for AIDS and Emerging Infectious Disease Control Health and Safety.
Lyle Moore Resiliency Officer Office of Emergency Preparedness and Response.
H1N1 Response in Virginia Reduce illness and death Minimize social disruption Karen Remley, MD, MBA, FAAP State Health Commissioner July 15, 2009.
ST. CLAIR COUNTY HEALTH DEPARTMENT EMERGENCY PREPAREDNESS AND RESPONSE
Presentation transcript:

1 Antivirals in the Draft CDC Pandemic Plan David K. Shay Influenza Branch National Center for Infectious Diseases Centers for Disease Control and Prevention

2 CDC’s Pandemic Plan Public Health Guidance for Community-Level Pandemic Influenza Planning Goal is to help the public health and medical communities across the nation respond to a pandemic Augments information for state and local partners described in the DHHS Pandemic Influenza Preparedness and Response Plan, which provides the framework for coordinated federal and state-level planning Due to DHHS by August 1

3 Purpose and aims I Provide guidance to public health agencies for the development of state-level pandemic influenza response plans, as recommended in Cross-Cutting Critical Benchmark #6 of the CDC and HRSA cooperative agreements for Public Health and Hospital Bioterrorism

4 Purpose and aims II Help healthcare partners address the medical challenges of pandemic influenza (e.g., large patient volume, occupational health risks, and targeting limited supplies of antiviral medications and vaccines)

5 Purpose and aims III Define the public health role in healthcare planning and preparedness for pandemic influenza Strengthen linkages between public health agencies and private sector partners -- including healthcare facilities, community- based organizations, clinical laboratories, and first responders -- to protect health and preserve essential services during a pandemic

6 CDC’s Federal Role in Pandemic Influenza Preparedness and Response CDC is lead agency in these areas: –Disease surveillance and laboratory diagnostics –Disease control and prevention strategies, including community containment measures, mitigation of travel-related transmission risk, and effective use of antiviral drugs and vaccines –Public health communication with the states, healthcare and public health organizations, ministries of health, and the World Health Organization –Public health investigations and research

7 11 Supplements in Plan 1. Disease Surveillance 2. Laboratory Diagnostics 3. Healthcare 4. Infection Control 5. Vaccine Use 6. Antiviral Drug Use – draft reviewed with APHL, ASTHO, NACCHO, CSTE on 5/27 7. Community Disease Control and Prevention 8. Mitigation of Travel- Related Transmission Risk 9. Public Health Communications 10. Psychosocial Issues 11. Clinical Guidelines

8 A. Use of Antivirals in Management of Cases and Clusters of Novel Influenza Use of Antivirals for Treatment Use of Antivirals for Prophylaxis of Contacts Use of Antivirals for Containment of Disease Clusters Recommendations for the Inter- Pandemic and Pandemic Alert Periods

9 B. Preparedness and Planning for Use of Antivirals During a Pandemic National Recommendations on Use of Antivirals during a Pandemic State Level Planning Procurement Distribution to Priority Groups Monitoring and Data Collection Supply and Distribution Antiviral Effectiveness Adverse Events Antiviral Drug Resistance Coordination with Bordering Jurisdictions Legal Preparedness Training Public Health Information Recommendations for the Inter- Pandemic and Pandemic Alert Periods

10 A. When Pandemic Influenza Is Reported Abroad B. When There is Limited Transmission of Pandemic Influenza in the United States C. When There is Widespread Transmission of Pandemic Influenza in the United States Recommendations for the Pandemic Period

11 Antiviral Drugs with Activity Against Influenza: Pharmacology, Side Effects, Prophylaxis, Treatment, Resistance M2 Ion Channel Inhibitors: Amantadine and Rimantadine Neuriminidase Inhibitors: Oseltamivir and Zanamivir Appendix

12 Antiviral Drugs in the Strategic National Stockpile As of May 2005, the Strategic National Stockpile contains 2.26 million treatment regimens of oseltamivir (capsules and suspension), and 5 million treatment regimens of rimantadine (tablets and syrup), with additional purchases of antivirals pending

13 …recommendations for optimal use of limited supplies of antivirals during a pandemic are under consideration by DHHS, in consultation with the National Vaccine Advisory Committee (NVAC), bioethicists, and other expert partners. During an actual pandemic these recommendations may be modified, based on the characteristics of the causative virus (e.g., drug susceptibilities, initial geographic distribution, fatality rate, age-specific morbidity and mortality rates) National Recommendations on Use of Antivirals

14 Priority groups for treatment, based on predicted medical risk, and the goal to reduce morbidity and mortality Priority groups for short- and long-term prophylaxis, based on predicted medical and occupational risk, and the goal to preserve healthcare and other essential services Effective antiviral use by healthcare providers, including: Strategies for administration to individual patients Strategies for retarding the development of drug resistance Size of SNS stockpile Recommendations will include:

15 Estimating the size and needs of priority groups in local jurisdictions Making arrangements for transport, receipt, storage, security, tracking, and delivery of: -- SNS antiviral stocks for use in treatment to hospitals, clinics, nursing homes, alternative care facilities, and other healthcare institutions -- SNS antiviral stocks for use in short-term prophylaxis (e.g., for direct contacts of infected patients) -- SNS antiviral stocks for use in long-term prophylaxis (e.g., for healthcare workers, public safety workers, and essential service providers). Developing a communication plan to explain the rationale for establishing these target groups Distribution to Priority Groups: recommendations for states

16 Will states request antivirals from SNS, or will they be distributed to states after a federal decision? What are the criteria for release of antivirals in SNS? -- What’s the process for requesting antivirals from SNS? -- How will requests be approved? -- Will there be a ‘reserve’? How large? How will SNS assets be divided amongst the states? A pro rata scheme based on population? How will states receive SNS assets? Will assets be delivered to SNS receipt, storage, staging (RSS) sites, to state health departments, or to local health departments and large integrated healthcare delivery systems? How can states best prepare to: -- Deliver antivirals to institutions/health care facilities during a pandemic? -- Use data management systems to track distribution? Questions about Distribution